These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 8517690)
41. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents. Aldridge KE; Henderberg A; Sanders CV J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826 [TBL] [Abstract][Full Text] [Related]
42. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem. Eley A; Greenwood D J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198 [TBL] [Abstract][Full Text] [Related]
43. Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes. De Luca F; Giraud-Morin C; Rossolini GM; Docquier JD; Fosse T Antimicrob Agents Chemother; 2010 Apr; 54(4):1547-54. PubMed ID: 20124004 [TBL] [Abstract][Full Text] [Related]
44. beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents. Jacobs MR; Spangler SK; Appelbaum PC Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1081-93. PubMed ID: 1295763 [TBL] [Abstract][Full Text] [Related]
45. Penicillin-binding proteins of Bacteroides fragilis and their role in the resistance to imipenem of clinical isolates. Ayala J; Quesada A; Vadillo S; Criado J; Píriz S J Med Microbiol; 2005 Nov; 54(Pt 11):1055-1064. PubMed ID: 16192437 [TBL] [Abstract][Full Text] [Related]
46. Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum. Bellais S; Poirel L; Naas T; Girlich D; Nordmann P Antimicrob Agents Chemother; 2000 Jan; 44(1):1-9. PubMed ID: 10602714 [TBL] [Abstract][Full Text] [Related]
47. Detection of resistance genes and susceptibility patterns in Bacteroides and Parabacteroides strains. Boente RF; Ferreira LQ; Falcão LS; Miranda KR; Guimarães PL; Santos-Filho J; Vieira JM; Barroso DE; Emond JP; Ferreira EO; Paula GR; Domingues RM Anaerobe; 2010 Jun; 16(3):190-4. PubMed ID: 20159050 [TBL] [Abstract][Full Text] [Related]
48. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains. Nagy E; Szóke I; Gacs M; Csiszár K Acta Microbiol Immunol Hung; 1995; 42(3):287-99. PubMed ID: 8548202 [TBL] [Abstract][Full Text] [Related]
49. Characterization of cephalosporin resistance in clinical isolates of Escherichia coli. Sawai T; Ando-Kuroda I; Murata T; Yamagishi S J Pharmacobiodyn; 1980 Jul; 3(7):364-6. PubMed ID: 7009827 [TBL] [Abstract][Full Text] [Related]
50. Relationship between penicillin-binding protein patterns and beta-lactamases in clinical isolates of Bacteroides fragilis with different susceptibility to beta-lactam antibiotics. Píriz S; Vadillo S; Quesada A; Criado J; Cerrato R; Ayala J J Med Microbiol; 2004 Mar; 53(Pt 3):213-221. PubMed ID: 14970246 [TBL] [Abstract][Full Text] [Related]
51. Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli. Takahashi I; Sawai T; Ando T; Yamagishi S J Antibiot (Tokyo); 1980 Sep; 33(9):1037-42. PubMed ID: 7002896 [TBL] [Abstract][Full Text] [Related]
52. Alterations to the penicillin-binding proteins in the Bacteroides fragilis group: a mechanism for non-beta-lactamase mediated cefoxitin resistance. Wexler HM; Halebian S J Antimicrob Chemother; 1990 Jul; 26(1):7-20. PubMed ID: 2211448 [TBL] [Abstract][Full Text] [Related]
53. Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei. Girlich D; Naas T; Bellais S; Poirel L; Karim A; Nordmann P Antimicrob Agents Chemother; 2000 Jun; 44(6):1470-8. PubMed ID: 10817695 [TBL] [Abstract][Full Text] [Related]
54. The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group. Malouin F; Lamothe F Can J Microbiol; 1987 Mar; 33(3):262-6. PubMed ID: 3105858 [TBL] [Abstract][Full Text] [Related]
55. Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase. Tsukamoto K; Ohno R; Sawai T J Bacteriol; 1990 Aug; 172(8):4348-51. PubMed ID: 2115867 [TBL] [Abstract][Full Text] [Related]
56. Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole. Jacobs MR; Spangler SK; Appelbaum PC Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):417-21. PubMed ID: 2387295 [TBL] [Abstract][Full Text] [Related]
57. Purification and characterization of a new beta-lactamase from Bacteroides uniformis. Hedberg M; Lindqvist L; Bergman T; Nord CE Antimicrob Agents Chemother; 1995 Jul; 39(7):1458-61. PubMed ID: 7492085 [TBL] [Abstract][Full Text] [Related]
58. Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilis. Cuchural GJ; Tally FP; Storey JR; Malamy MH Antimicrob Agents Chemother; 1986 May; 29(5):918-20. PubMed ID: 3488018 [TBL] [Abstract][Full Text] [Related]
59. Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility. Piddock LJ; Wise R J Antimicrob Chemother; 1987 Feb; 19(2):161-70. PubMed ID: 3571041 [TBL] [Abstract][Full Text] [Related]